Board approves 5 lakh warrants preferential issue to promoter

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹150.45

prior close

₹152.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.4% vs market

Pharmaceuticals peers, median of 164sector-0.1%-0.9% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

-3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.4-1.4-0.1-0.9

Next day

+0.9+1.8-0.9+0.5+0.4

+12.7+0.5+12.2+0.0+12.6

+9.7+0.9+8.8+0.6+9.1

+8.9+0.3+8.6-0.1+9.0

+11.0+1.4+9.5+0.2+10.8

+6.3+3.2+3.1+0.8+5.6

15d

+30.3+5.4+24.9+2.7+27.6

+25.0+6.4+18.6+1.4+23.6

+14.3+6.3+8.0+3.6+10.7

-0.3-3.6+3.3-4.2+3.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved preferential issue of up to 5 lakh fully convertible warrants to promoter Mr. Ashwani Khemka at INR 147.39 per warrant, aggregating about INR 7.37 crore. Convertible into equity shares within 18 months. Promoter stake will rise from 29.88 percent to 32.62 percent on full conversion. Also approved material related party transaction with subsidiary SPL Infusion Private Limited. Postal ballot notice issued for shareholder approval.

Likely market impact

Promoter capital infusion signals confidence but will dilute minority shareholders on conversion. Awaiting shareholder nod via postal ballot.